Cell Lysis & Disruption

Cell Lysis & Disruption Market Predicted to Reach USD 7.1 billion by 2030 Cell Lysis & Disruption Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2021 - 2030

Share This Article

As per the experts, the cell lysis & disruption market is predicted to record a growth rate of 6.7% from 2021-2030 and is projected to reach US$ 7.1 billion by 2030.

The study provides the overall revenue of the global cell lysis & disruption market from 2017 to 2030, considering 2020 as the base year and 2030 as the forecast year.

The global cell lysis & disruption market research report gives a brief summary of definitions, size analysis, and place of production, sales, applications, types, and major players/key vendors of the cell lysis & disruption industry. The report presents fresh perspectives on opportunities and challenges in a significantly transformed post-COVID-19 marketplace. This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.

We customize your report according to your research need. REQUEST SAMPLE OR CUSTOMIZED COPY OF THIS REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1292

Crucial factors accountable for market growth are:

  • Growing demand from the biopharmaceutical industry
  • Rapid growth of the biopharmaceutical industry
  • Presence of numerous biotechnology companies
  • Increased investments in the research and development by the private players
  • Development of the personalized medications
  • Growing demand for the bioprocess solutions due to the development of biologics
  • Rising adoption of ultrasonic homogenization
  • Growing uses of instrument such as sonicators and homogenizers in cell fractionation

Report Highlights

  • Based on the product, the instrument segment is estimated to be the most opportunistic market owing to the rising uses of instruments like blender, homogenizers, and sonicators. These instruments are very effective in extracting large samples and large volumes of mammalian cells with less oxidation during extraction.
  • By cell type, the mammalian cells were the dominating segment in 2020. Mammalian cells have wide and extensive uses in the production of the key biopharma products like viral vaccines, gene based therapies, and cell-based therapies. The growing incidences of chronic diseases and increased adoption of gene therapies for treatment is exponentially propelling the segment growth.
  • By application, the protein isolation dominated the market in 2020. The increased demand for the efficient protein extracting technologies is propelling the segment growth because of the loss of protein cells through oxidation during the extraction of proteins from the mammalian cells.
  • By end use, the pharma & biotechnology companies registered the highest market share in 2020 due to the increased usage of cell lysis technology for conducting researches on the molecular bilogy.

Report Scope of the Cell Lysis and Disruption Market

Report Coverage Details
Market Size US$ 7.1 Billion by 2030
Growth Rate CAGR of 6.7% From 2021 to 2030
Base Year 2020
Forecast Period 2021 to 2030
Segments Covered Product, Cell Type, Application, End User, Region
By Product
  • Reagents
  • Instruments
By Application
  • Cell Organelle Isolation
  • Protein Isolation
  • Downstream Processing
  • Nucleic Acid Isolation
Companies Mentioned Thermo Fisher Scientific, Inc., Becton Dickinson & Company, Danaher Corporation, Qiagen NV, Parr Instrument Company, Claremont BioSolutions, Covaris Inc., Merck KGaA, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd.

Regional Snapshots

North America dominated the global cell lysis & disruption market in 2020 and is expected to retain its dominance during the forecast period. This is attributed to the existence of huge number of research organizations coupled increased investments by the private players for the research and development of various biopharmaceutical products. According to the Pharmaceutical Research and Manufacturers Association, around US$ 80 billion was invested in the research & development of biopharmaceuticals in 2018 in US. Moreover, the US holds around one-third of the global biopharmaceutical market and hence with the growth of the biopharmaceutical industry in US, the cell lysis and disruption market in North America is also anticipated to grow at a rapid pace. Moreover, growing prevalence of chronic disease along with the growing geriatric population and rising adoption of cell therapies is positively boosting the demand for the cell lysis technology in the region.

On the other hand, the Asia Pacific is expected to be the fastest-growing cell lysis and disruption market during the forecast period. The demand for the cell therapy for cancer treatment is gaining rapid traction in the markets such as China, Japan, and South Korea, which is augmenting the market growth. Further, the rising investments in the region for the development of the biologic industry are expected to significantly fuel the market growth during the forecast period.

  Some of the key highlights of the report are:

  • Market Demand Outlook – The report offers refined forecasts on potential growth prospects for the market. Based on data derived after thorough research by a team of expert analysis, Precedence Research presents the most precise rate of growth for the market for the assessment period starting from 2021 – 2030.
  • Supply Chain Analysis – The purpose of the survey is to help companies identify potential scope for supply chain expansion. The study also presents analysis of unprecedented threats.
  • Competitive Landscape Analysis – Some of the leading companies operating in the cell lysis & disruption market are profiled in the market study. The report also underscores winning strategies adopted over the last few years and gauges impact of the same on growth trajectory exhibited by the market over the last few years.

Top Players Contending in the Market:

The key companies are aiming towards advanced innovations and are predictable to dominate the target market. Foremost players inspiring in the global cell lysis & disruption market are as follows:

  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Qiagen NV
  • Parr Instrument Company
  • Covaris Inc.
  • Merck KGaA
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Claremont BioSolutions
  • Becton Dickinson & Company

Segments Covered in the Report

By Product

  • Instruments
  • Reagents

By Cell Type

  • Bacteria Cells
  • Mammalian Cells
  • Plant Cells
  • Yeast/Fungi/Algae

By Application

  • Cell Organelle Isolation
  • Protein Isolation
  • Downstream Processing
  • Nucleic Acid Isolation

By End Use

  • Hospitals and Diagnostic Laboratories
  • Cell Banks
  • Academic and Research Institutions
  • Pharma & Biotechnology Companies

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

Why should you invest in this report?

If you are aiming to enter the global cell lysis & disruption market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for cell lysis & disruption are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Cell Lysis & Disruption Market, By Product

7.1. Cell Lysis & Disruption Market, by Product Type, 2021-2030

7.1.1. Instruments

7.1.1.1. Market Revenue and Forecast (2017-2030)

7.1.2. Reagents

7.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 8. Global Cell Lysis & Disruption Market, By Application

8.1. Cell Lysis & Disruption Market, by Application, 2021-2030

8.1.1. Cell Organelle Isolation

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Protein Isolation

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Downstream Processing

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Nucleic Acid Isolation

8.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Cell Lysis & Disruption Market, By Cell Type 

9.1. Cell Lysis & Disruption Market, by Cell Type, 2021-2030

9.1.1. Bacteria Cells

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Mammalian Cells

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Plant Cells

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Yeast/Fungi/Algae

9.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Cell Lysis & Disruption Market, By End Use Type 

10.1. Cell Lysis & Disruption Market, by End Use Type, 2021-2030

10.1.1. End Use

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Cell Banks

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Academic and Research Institutions

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Pharma & Biotechnology Companies

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Cell Lysis & Disruption Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.1.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.1.5. U.S.

11.1.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.1.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.1.6. Rest of North America

11.1.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.6.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.1.6.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.2.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.2.5. UK

11.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.2.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.2.6. Germany

11.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.6.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.2.6.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.2.7. France

11.2.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.7.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.2.7.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.2.8. Rest of Europe

11.2.8.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.8.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.8.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.2.8.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.3.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.3.5. India

11.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.3.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.3.6. China

11.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.6.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.3.6.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.3.7. Japan

11.3.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.7.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.3.7.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.3.8. Rest of APAC

11.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.8.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.8.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.3.8.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.4.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.4.5. GCC

11.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.4.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.4.6. North Africa

11.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.6.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.4.6.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.4.7. South Africa

11.4.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.7.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.4.7.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.4.8. Rest of MEA

11.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.8.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.8.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.4.8.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.5.5. Brazil

11.5.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.5.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)

11.5.6. Rest of LATAM

11.5.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.6.3. Market Revenue and Forecast, by Cell Type (2017-2030)

11.5.6.4. Market Revenue and Forecast, by End Use Type (2017-2030)

Chapter 12. Company Profiles

12.1. Thermo Fisher Scientific, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Danaher Corporation

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Qiagen NV

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Parr Instrument Company

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Covaris Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Merck KGaA

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Bio-Rad Laboratories

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. F. Hoffmann-La Roche Ltd.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Claremont BioSolutions

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Becton Dickinson & Company

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase This Premium Research Report @ https://www.precedenceresearch.com/checkout/1292

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defence, among different ventures, present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Follow us on LinkedIn | Twitter | Facebook

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →